Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $154M (100.0% shares, 0.0% debt)

Holdings (13)

BBNX Beta Bionics Inc. 18.7%

Value $28.95M Shares 1,988,287 Est. Cost $18.64 Unrealized -24.1%

KMTS Kestra Med Technologies Ltd. 17.7%

Value $27.29M Shares 1,645,893 Est. Cost $22.98 Unrealized -5.0%

UPB Upstream Bio Inc. 14.5%

Value $22.36M Shares 2,036,293 Est. Cost $22.33 Unrealized -58.6%

NUVB Nuvation Bio 13.9%

Value $21.53M Shares 11,042,728 Est. Cost $11.18 Unrealized -81.4%

BCAX Bicara Therapeutics Inc. 13.3%

Value $20.48M Shares 2,204,650 Est. Cost $25.50 Unrealized -53.3%

REPL Replimune Group 11.9%

Value $18.35M Shares 1,975,203 Est. Cost $17.40 Unrealized -49.9%

LXEO Lexeo Therapeutics 3.1%

Value $4.762M Shares 1,184,636 Est. Cost $12.69 Unrealized -74.1%

— Ikena Oncology 2.0%

Value $3.014M Shares 2,249,123 Est. Cost $28.25 Unrealized —

SANA Sana Biotechnology, Inc. 1.5%

Value $2.303M Shares 843,750 Est. Cost $32.56 Unrealized -93.7%

ALMS Alumis Inc. 1.3%

Value $1.96M Shares 653,223 Est. Cost $13.30 Unrealized -64.5%

ENGN enGene Holdings Inc. 1.2%

Value $1.916M Shares 526,357 Est. Cost $10.40 Unrealized -63.9%

IMUX Immunic Inc. 0.8%

Value $1.248M Shares 1,788,160 Est. Cost $13.89 Unrealized -93.4%

ENGNW enGene Holdings Inc. 0.2%

Value $273K Shares 321,502 Est. Cost $0.85 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBNX	Beta Bionics Inc.	1,988,287	$28.95M	18.7%	$18.64	-24.1%	Common Stock	08659B102
KMTS	Kestra Med Technologies Ltd.	1,645,893	$27.29M	17.7%	$22.98	-5.0%	Common Stock	G52441105
UPB	Upstream Bio Inc.	2,036,293	$22.36M	14.5%	$22.33	-58.6%	Common Stock	91678A107
NUVB	Nuvation Bio	11,042,728	$21.53M	13.9%	$11.18	-81.4%	Common Stock Class A	67080N101
BCAX	Bicara Therapeutics Inc.	2,204,650	$20.48M	13.3%	$25.50	-53.3%	Common Stock	055477103
REPL	Replimune Group	1,975,203	$18.35M	11.9%	$17.40	-49.9%	Common Stock	76029N106
LXEO	Lexeo Therapeutics	1,184,636	$4.762M	3.1%	$12.69	-74.1%	Common Stock	52886X107
—	Ikena Oncology	2,249,123	$3.014M	2.0%	$28.25	—	Common Stock	45175G108
SANA	Sana Biotechnology, Inc.	843,750	$2.303M	1.5%	$32.56	-93.7%	Common Stock	799566104
ALMS	Alumis Inc.	653,223	$1.96M	1.3%	$13.30	-64.5%	Common Stock	022307102
ENGN	enGene Holdings Inc.	526,357	$1.916M	1.2%	$10.40	-63.9%	Common Stock	29286M105
IMUX	Immunic Inc.	1,788,160	$1.248M	0.8%	$13.89	-93.4%	Common Stock	4525EP101
ENGNW	enGene Holdings Inc.	321,502	$273K	0.2%	$0.85	—	Warrant	29286M113